Centerline Wealth Advisors’s AbbVie ABBV Stock Holding History

Centerline Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	+824	New	+$177K	0.07%	77

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Centerline Wealth Advisors's ABBV Position: Q2 2026 in Review

Centerline Wealth Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 824 shares worth $207K. The stake represents 0.07% of the portfolio and ranks #77 among its holdings.

1,509 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Centerline Wealth Advisors held 824 shares of AbbVie worth $207K as of Q2 2026.
AbbVie was a new Centerline Wealth Advisors position in Q2 2026.
AbbVie made up 0.07% of Centerline Wealth Advisors's portfolio in Q2 2026, its #77 holding.
1,509 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Centerline Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.